While 34% of women reported moderate, severe, or very severe menopause symptoms, most women did not seek care for symptoms.
The science around hormone therapy to treat menopause has changed a lot since the FDA issued warning labels 20 years ago. Now ...
The FDA plans to remove labels warning of dementia and cancer from hormone-replacement therapy drugs for women taking them ...
FDA seeks to lift “black box" warnings from menopause hormone therapy, citing evidence that benefits outweigh risks.
The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.